Portal de investigación
ESTUDIO OBSERVACIONAL LONGITUDINAL DE 5 AÑOS DE LA HISTORIA NATURAL Y EL MANEJO DE PACIENTES CON CARCINOMA HEPATOCELULAR.
Datos básicos
- Código:
- TAR-SOR-2017-01
- Protocolo:
- TAR-SOR-2017-01
- EUDRACT:
- NCT:
- Centro:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Dotación:
- Año de incio:
- 2018
- Año de finalización:
- 2023
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
Resultados del Ensayo Clínico
A multicenter study to assess the incidence of hepatocellular carcinoma recurrence after liver transplantation in patients treated with direct-acting antivirals for chronic hepatitis C
Gorgen, A; (...); Sapisochin, G
Meeting Abstract. 2018
A population-based screening for hepatitis C antibodies and active infection using a point-of-care test in a low prevalence area.
Carvalho-Gomes Â; (...); Berenguer M
Article. 10.1371/journal.pone.0228351. 2020
Association of Cardiac Abnormalities to the Frail Phenotype in Cirrhotic Patients on the Waitlist: From the Functional Assessment in Liver Transplantation Study
Puchades, L; (...); Lai, JC
Article. 10.1097/TP.0000000000002025. 2018
Baseline features of hepatitis C patients associated to prescription of pangenotypic antiviral treatments: results from the real-world Spanish Hepa-C registry
Turnes, Juan; (...); Perez Cachafeiro, Santiago
Meeting Abstract. 2020
Bismuth quadruple regimen with tetracycline or doxycycline versus three-in-one single capsule as third-line rescue therapy forHelicobacter pyloriinfection: Spanish data of the EuropeanHelicobacter pyloriRegistry (Hp-EuReg)
Nyssen, OP; (...); Gisbert, JP
Article. 10.1111/hel.12722. 2020
Brain abscesses in early post-liver transplantation.
Mínguez Sabater A; (...); Prieto Castillo M
Case Reports. 10.1016/j.eimc.2021.02.002. 2021
Brain abscesses in early post-liver transplantation.
Minguez Sabater, Alejandro; (...); Prieto Castillo, Martin
Article. 10.1016/j.eimce.2021.09.007. 2021
Can endothelial biomarkers before liver transplantation together with classical cardiovasculat risk factors be useful to predict cardiovascular risk after liver transplantation
Herreras Lopez, Julia; (...); Aguilera Sancho, Victoria
Meeting Abstract. 2022
Can endothelial biomarkers before LT together with classical cardiovascular risk factors be useful to predict cardiovascular risk after LT?
Herreras, J.; (...); Aguilera, V.
Article. 2022
CLINICAL PRESENTATION AND OUTCOMES OF DE NOVO HEPATITIS B VIRUS INFECTION AFTER LIVER TRANSPLANTATION IN SPAIN.
Pascasio Acevedo, Juan Manuel; (...); Manuel Sousa, Jose
Meeting Abstract. 2019
CMV reactivation after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study
Garcia-Garcia, Sonia; (...); Aguilera Sancho, Victoria
Meeting Abstract. 2023
CMV reactivation is associated with lower hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT)
Aguilera Sancho, Victoria; (...); Berenguer, Marina
Meeting Abstract. 2022
Comprehensive analysis and insights gained from long-term experience of the Spanish DILI registry.
Stephens C; (...); Andrade RJ
Article. 10.1016/j.jhep.2021.01.029. 2021
Consensus document of the Spanish Association for Study of the Liver on the treatment of hepatitis B virus infection (2020).
Rodríguez M; (...); García-Samaniego J
Article. 10.1016/j.gastrohep.2020.03.011. 2020
COVID vaccination among liver transplant recipients: A EASL-ESOT/ELITA-ILTS multi society survey
Vinaixa, Carmen; (...); Berenguer, Marina
Meeting Abstract. 2022
COVID vaccination among liver transplant recipients: an EASL-ESOT/ELITA-ILTS multi-society international survey
Vinaixa, C.; (...); Berenguer, M.
Meeting Abstract. 2022
COVID-19 and liver transplantation
Editorial Material. 10.1038/s41575-020-0347-z. 2020
Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation
Rodriguez-Peralvarez, Manuel; (...); Gomez Bravo, Miguel Angel
Meeting Abstract. 2022
Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation.
Rodríguez-Perálvarez M; (...); Bernal-Bellido C
Article. 10.1111/ajt.17021. 2022
Cytomegalovirus reactivation in liver transplant recipients due to hepatitis C cirrhosis is associated with higher cardiovascular risk - an observational, retrospective study
Aguilera, V; (...); Berenguer, M
Article. 10.1111/tri.13145. 2018
Cytomegalovirus reactivation is associated with lower hepatocelullar carcinoma recurrence rates after liver transplantation
Aguilera Sancho, Victoria; (...); Rodriguez-Peralvarez, Manuel
Meeting Abstract. 2023
Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients
Marcos, AC; (...); Pons, JA
Meeting Abstract. 2021
Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients
Caballero-Marcos, A; (...); Pons, JA
Article. 10.1111/ajt.16599. 2021
Characteristics, trends and outcomes of liver transplantation (LT) for primary sclerosing cholangitis (PSC) in female patients: analysis of the European Liver Transplantation Registry (ELTR)
Di Maira, T; (...); European Liver & Intestine
Meeting Abstract. 2021
Characteristics, Trends, and Outcomes of Liver Transplantation for Primary Sclerosing Cholangitis in Female Versus Male Patients: An Analysis From the European Liver Transplant Registry
Berenguer M; (...); European Liver Intestine Transplan
Article. 10.1097/TP.0000000000003542. 2021
Decreased Long-Term Severe Acute Respiratory Syndrome Coronavirus 2-Specific Humoral Immunity in Liver Transplantation Recipients 12 Months After Coronavirus Disease 2019.
Caballero-Marcos, Aranzazu; (...); Salcedo, Magdalena
Article. 10.1002/lt.26389. 2022
Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure.
Chen Q; (...); Quer J
Article. 10.1016/j.antiviral.2019.104694. 2020
Delisting of Liver Transplant Candidates with Chronic HCV Infection after Viral Erradication: Outcome 2 Years after Delisting. A European Study
Vinaixa, C; (...); Duvuox, C
Meeting Abstract. 10.1097/01.tp.0000542536.91165.49. 2018
Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study (vol 18, pg 2513, 2018)
Manzardo, C.; (...); Samuel, D.
Correction. 10.1111/ajt.15244. 2019
DRESS cases included in the Spanish and Latin-American DILI registries: clinical phenotype and outcome
Medina-Caliz, I; (...); Andrade, RJ
Meeting Abstract. 10.1016/S0168-8278(18)31459-4. 2018
Effectiveness of 8 weeks of glecaprevir/pibrentasvir in treatment-naive hepatitis C patients with liver cirrhosis: results from the real-world Spanish Hepa-C registry
Turnes, Juan; (...); Perez Cachafeiro, Santiago
Meeting Abstract. 2020
Efficacy and safety of glecaprevir/pibrentasvir for the pangenotypic treatment of chronic hepatitis C in former intravenous drug users: Subanalysis from a Spanish real-world cohort (Hepa-C)
Puigvehi, M; (...); Carrion, JA
Meeting Abstract. 10.1016/S0618-8278(19)30399-8. 2019
Epidemiological pattern, incidence and outcomes of COVID-19 in liver transplant patients.
Colmenero J; (...); Pons JA
Article. 10.1016/j.jhep.2020.07.040. 2021
-
-
-
PlumX Metrics
- Citations
- Citation Indexes: 279
- Captures
- Readers: 257
- Mentions
- Blog Mentions: 1
- News Mentions: 1
European Registry on Helicobacter pylori Management: Effectiveness of First and Second-Line Treatment in Spain.
Caldas M; (...); Hp-EuReg Investigators
Article. 10.3390/antibiotics10010013. 2020
Evaluation and Management of Liver Transplant Candidates With Prior Nonhepatic Cancer: Guidelines From the ILTS/SETH Consensus Conference.
Salcedo, Magdalena; (...); Line, Pal-Dag
Article. 10.1097/TP.0000000000003997. 2022
Everolimus plus minimized tacrolimus on kidney function in liver transplantation: REDUCE, a prospective, randomized controlled study.
Gómez-Bravo M; (...); Santoyo J
Article. 10.17235/reed.2022.8549/2021. 2022
External validation of models to predict hepatocellular carcinoma (HCC) in HCV SVR F3-F4 patients
Sahuco, Ivan; (...); Berenguer, Marina
Meeting Abstract. 2023
Fat and liver transplantation: clinical implications
Vinaixa, C, Selzner, N, Berenguer, M
Review. 10.1111/tri.13288. 2018
Frailty and Sarcopenia in Acute-on-Chronic Liver Failure
Renau, LP; (...); Berenguer M
Article. 10.1002/hep4.1722. 2021
Global impact of the first wave of COVID-19 on liver transplant centers: A multi-society survey (EASL-ESOT/ELITA-ILTS).
Russo FP; (...); Polak WG
Article. 10.1016/j.jhep.2021.09.041. 2021
Good posttransplant outcome using donors after cardiac death (DCD) when applying strict selection criteria
de la Varga, MF; (...); Castillo, MP
Meeting Abstract. 2021
Good post-transplant outcomes using liver donors after circulatory death when applying strict selection criteria: A propensity-score matched-cohort study.
Fernandez-de la Varga, Margarita; (...); Aguilera, Victoria
Article. 10.1016/j.aohep.2022.100724. 2022
Hepatitis B surface antigen loss after discontinuing nucleos(t)ide analogue for treatment of chronic hepatitis B patients is persistent in White patients
Suarez, E; (...); Simon, MA
Article. 10.1097/MEG.0000000000001289. 2019
Hepatobiliary and Pancreatic: A fatal case of extensive splanchnic vein thrombosis in a patient with Covid-19.
Del Hoyo J; (...); Aguilera V
Editorial Material. 10.1111/jgh.15174. 2020
HIV infection is not associated with increased cardiovascular (CV) risk in liver transplant (LT) recipients: a single centre comparative study
Vinaixa, C.; (...); Prieto, M.
Meeting Abstract. 2019
HIV Infection Is Not Associated with Increased Cardiovascular Risk in Liver Transplant Recipients: A Single Center Comparative Study
Herreras, J; (...); Berenguer, M
Meeting Abstract. 2018
Immunosuppression in liver transplant.
Di Maira T, Little EC, Berenguer M
Review. 10.1016/j.bpg.2020.101681. 2020
Impact of comorbidities on liver transplantation: a prospective and multicentric study
Serrano, Trinidad; (...); Salcedo, Magdalena
Meeting Abstract. 2022
Incidence and prognostic impact of cancer after liver transplantation
Rodriguez-Peralvarez, Manuel; (...); Angel Gomez-Bravo, Miguel
Meeting Abstract. 2020
Incidence of de novo tumors after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study
Chafer, Isabel Terol; (...); Sancho, Victoria Aguilera
Meeting Abstract. 2023
Introduction to hepatitis C virus infection: Overview and history of hepatitis C virus therapies
Puchades Renau, L, Berenguer, M
Review. 10.1111/hdi.12647. 2018
Is hepatitis B immunoglobulin necessary for hepatitis D prophylaxis after liver transplantation? A retrospective multicenter study of a cohort of 174 patients
Rodriguez-Tajes, Sergio; (...); Forns, Xavier
Meeting Abstract. 2020
Long term follow-up in HCV infected patients with end stage chronic kidney disease after DAA therapy
Martinez-Camprecios, J; (...); Buti, M
Meeting Abstract. 2021
Long-Term Effectiveness, Safety, and Patient- Reported Outcomes of Self-Administered Subcutaneous Hepatitis B Immunoglobulin in Liver Post-Transplant Hepatitis B Prophylaxis: A Prospective Non-Interventional Study
Roche B; (...); Samuel D
Article. 10.12659/AOT.936162. 2022
Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy
Martinez-Camprecios, Joan; (...); Buti, Maria
Article. 10.1016/j.gastrohep.2022.12.004. 2023
-
-
PlumX Metrics
- Citations
- Policy Citations: 1
- Citation Indexes: 1
- Captures
- Readers: 13
- Mentions
- News Mentions: 1
Metabolic syndrome before liver transplantation: does it have an impact on post liver transplantation outcomes?
Herreras Lopez, Julia; (...); Aguilera, Victoria
Article. 10.17235/reed.2022.8384/2021. 2022
Milan-out Criteria and Worse Intention-to-Treat Outcome Postliver Transplantation.
Herreras J; (...); Berenguer M
Article. 10.1097/TXD.0000000000000934. 2019
mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis EScreening in patients with immune impairment and increased transaminases levels).
Riveiro-Barciela, Mar; (...); Esteban, Rafael
Article. 10.1016/j.gastrohep.2023.01.010. 2023
Out of Milan criteria and worse intetion to treat results at large liver transplant center
Lopez, JH; (...); Haym, MB
Meeting Abstract. 10.1016/S0168-8278(18)30613-5. 2018
Outcome of liver transplant candidates "delisted" after successful treatment of HCV infection
Perricone, G; (...); ELITA
Meeting Abstract. 2018
Out-of-Milan criteria and worse intention-to-treat results at a large liver transplant (LT) centre
Herreras, J; (...); Berenguer, M
Meeting Abstract. 2018
Out-of-Milan HCC criteria and worse intention-to-treat results following liver transplantation
Herreras, J.; (...); Berenguer, M.
Meeting Abstract. 2019
OVERCOMING BARRIERS TO CARE FOR DELTA INFECTED PATIENTS
Carvalho-Gomes, Angela; (...); Berenguer, Marina
Meeting Abstract. 2022
Overcoming barriers to care for Delta infected patients
Bono, Ariadna; (...); Berenguer, Marina
Meeting Abstract. 2023
Performance of the OraQuick Hepatitis C virus antibody test in oral fluid and fingerstick blood before and after treatment-induced viral clearance
Pallares, C; (...); Lopez-Labrador, FX
Article. 10.1016/j.jcv.2018.02.016. 2018
Peritransplant Antiviral Treatment of Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients
Vinaixa, C; (...); Prieto, M
Letter. 10.1002/lt.25297. 2018
Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis.
Castelló B; (...); Berenguer M
Article. 10.1016/j.aohep.2019.06.014. 2019
Proceedings of the 25th Annual Congress of the International Liver Transplantation Society.
Chadha R; (...); Bhangui P
Review. 10.1097/TP.0000000000003160. 2020
Proceedings of the 26th Annual Virtual Congress of the International Liver Transplantation Society.
Kalisvaart, Marit; (...); Kirchner, Varvara
Article. 10.1097/TP.0000000000004183. 2022
Proceedings of the 27th Annual Congress of the International Liver Transplantation Society.
Campos-Varela, Isabel; (...); De Martin, Eleonora
Article. 10.1097/TP.0000000000004637. 2023
Prognosis of severe HBV reactivation in Western countries: role of the MELD score
Poli, E; (...); Coilly, A
Meeting Abstract. 2021
Real-world evidence of the effectiveness of ombitasvir-paritaprevir/r ± dasabuvir ± ribavirin in patients monoinfected with chronic hepatitis C or coinfected with human immunodeficiency virus-1 in Spain.
Manuel Sousa J; (...); Manzanares A
Article. 10.1371/journal.pone.0225061. 2019
Remnant vital tissue following locoregional therapy for hepatocellular carcinoma: another player in the game
Editorial Material. 10.1111/tri.13274. 2018
SIMILAR POST-TRANSPLANT OUTCOMES USING DONORS AFTER CARDIAC DEATH WHEN APPLYING STRICT SELECTION CRITERIA
de la Varga, MF; (...); Aguilera, V
Meeting Abstract. 2021
Simple score to assess cardiovascular risk post-liver transplantation
Di Maira, T; (...); Berenguer, M
Meeting Abstract. 2021
SIMPLE SCORE TO ASSESS CARDIOVASCULAR RISK POST-LIVER TRANSPLANTATION
Di Maira, Tommaso; (...); Berenguer, Marina
Meeting Abstract. 2022
Survey to evaluate the implementation of the recommendations on the comprehensive diagnosis of viral hepatitis in a single extraction: where are we?
Cabezas, Joaquin; (...); Crespo, Javier
Meeting Abstract. 2023
THE IMPACT OF DIRECT ACTING ANTIVIRALS ON HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION: A MULTICENTRIC RETROSPECTIVE STUDY
Gorgen, A; (...); Sapisochin, G
Meeting Abstract. 2019
The Impact of Direct-acting Antivirals on Overall Mortality and Tumoral Recurrence in Patients With Hepatocellular Carcinoma Listed for Liver Transplantation: An International Multicenter Study
Gorgen, A; (...); Sapisochin, G
Article. 10.1097/TP.0000000000003115. 2020
THE PRESENCE OF METABOLIC SYNDROME BEFORE TRANSPLANTATION INCREASE THE RISK OF CARDIOVASCULAR EVENTS FOLLOWING LIVER TRANSPLANTATION
Herreras, J; (...); Aguilera, V
Meeting Abstract. 2021
The role of prehabilitation on short-term outcomes after liver transplantation - A review of the literature and expert panel recommendations.
Vinaixa C; (...); Samuel D
Article. 10.1111/ctr.14686. 2022
Trends in liver transplantation for acute liver failure. A Spanish multicenter study
Conde, Isabel; (...); Berenguer, Marina
Meeting Abstract. 2022
Trends in liver transplantation for acute liver failure: a Spanish multicenter study
Conde, I.; (...); Berenguer, M.
Meeting Abstract. 2022
Universal access to direct-acting antivirals treatment is not not enough to prevent late stage presentation of hepatitis C infection
Cabezas, J; (...); Crespo, J
Meeting Abstract. 10.1016/S0618-8278(19)30970-3. 2019
VI consensus document by the Spanish Liver Transplantation Society
Pardo, F; (...); Briceno, J
Article. 10.1016/j.ciresp.2017.12.013. 2018
VI consensus document by the Spanish Liver Transplantation Society
Pardo, F; (...); Briceno, J
Article. 10.1016/j.gastrohep.2018.05.012. 2018
Worldwide variations in COVID-19 vaccination policies and practices in liver transplant settings: results of a multi-society global survey.
Di Maira, Tommaso; (...); Berenguer, Marina
Article. 10.3389/frtra.2023.1332616. 2023